Cellens Announces Collaboration with Bruker BioAFM to Advance Mechanobiology Technology for Cancer Detection
Bruker Corporation (BRKR)
Last bruker corporation earnings: 10/31 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.bruker.com/investors/default.aspx
Company Research
Source: Business Wire
BOSTON--(BUSINESS WIRE)--Cellens, Inc., an early-stage cancer diagnostic company pioneering in applying mechanobiology and machine learning analysis today announced that it is collaborating with Bruker BioAFM, a business unit of Bruker (Nasdaq: BRKR), to develop the world’s first clinical diagnostic tests that leverage multi-parametric, single-cell biophysical markers and machine learning. Based on cellular biophysical markers attained using Bruker’s advanced atomic force microscopy, Cellens is developing its platform for detecting bladder cancer using voided urine samples from cancer patients. The technology has shown outstanding sensitivity and specificity in pilot clinical studies.There are clear and unmet challenges in detecting and monitoring the recurrence of bladder cancer that Cellens can address for patients and clinicians. Accurate, non-invasive testing for bladder cancer will enable physicians to guide patients to endoscopic or surgical treatment faster, improve patient
Show less
Read more
Impact Snapshot
Event Time:
BRKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRKR alerts
High impacting Bruker Corporation news events
Weekly update
A roundup of the hottest topics
BRKR
News
- Assessment of the Dermatology Diagnostic Devices Market, 2020-2030, Featuring Strategic Analysis of Canfield Scientific, Leica Microsystems, Welch Allyn, Bruker, Heine Optotechnik & More [Yahoo! Finance]Yahoo! Finance
- Here's Why Bruker Corporation (BRKR) Fell in Q2 [Yahoo! Finance]Yahoo! Finance
- Should You Consider Retaining Bruker Stock in Your Portfolio Now? [Yahoo! Finance]Yahoo! Finance
- Preclinical Imaging (In-VIVO) Strategic Research Report 2023-2030: Adoption of AI and Machine Learning in Image Analysis Drives Market Dynamics [Yahoo! Finance]Yahoo! Finance
- Bruker Co. (NASDAQ: BRKR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $78.00 price target on the stock.MarketBeat
BRKR
Earnings
- 8/6/24 - In-Line
BRKR
Sec Filings
- 8/16/24 - Form 4
- 8/15/24 - Form 144
- 8/13/24 - Form 4
- BRKR's page on the SEC website